Rights and permissions
About this article
Cite this article
Darbepoetin alfa improves QOL for myelodysplastic syndromes. Inpharma Wkly. 1526, 9 (2006). https://doi.org/10.2165/00128413-200615260-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615260-00020